The Global Antithyroid Drug Market report segments the market by type (Thiourea, Iodine and Iodide, Radioiodine, β Receptor Blockers) and by application (Medical Treatment of Hyperthyroidism, Preparation for Thyroid Surgery, Treatment of Thyroid Crisis). This report covers the key market players such as Shanghai Huanghai Pharmaceutical Co., Ltd, Merck KGaA, Lomapharm Rudolf Lohmann GmbH KG, Herbrand Pharmaceutical Chemistry Co., Ltd, Beijing Tongjida Pharmaceutical Co., Ltd, Shanghai Zhaohui Pharmaceutical Co., Ltd, Guangzhou Kanghe Pharmaceutical Co., Ltd, Hunan Hansen Pharmaceutical Co., Ltd, World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd, Haimani Pharmaceutical Co., Ltd, Shanghai McLin Biochemical Technology Co., Ltd, Shanghai Yuanye Bio-Technology Co., Ltd, Amgen Inc, AbbVie Deutschland GmbH & Co.KG, Centrix Pharmaceutical Inc., Pfizer Inc., Actavis Totowa LLC, Caraco Pharmaceutical Laboratories, Boca Pharmacal Inc., Heritage Pharmaceuticals Inc., Par Pharmaceutical Inc, Sandoz Pharmaceuticals Inc..
The Antithyroid Drug industry report is a complete market study which ensures availability of insightful data and strategic information. Market statistics such as global Antithyroid Drug market size, estimated and forecasted data for next 5 years with breakdown at regional and country level is covered in the report. The market segmentation by type and application along with manufacturers profile and share gives a clear understanding of the market dynamics. The analysis on sales along with the study of latest developments in the past years - covering product launches, mergers and technological innovation is covered in the report.
The report on Antithyroid Drug market explores the upcoming opportunities in the industry, thus assisting in strategic decision making by the reader. The report covers volume and/or revenue (as applicable) data and the CAGR of the market calculated considering multiple quantitative and qualitative analytical tools.
Market segment by Type, covers
- Thiourea
- Iodine and Iodide
- Radioiodine
- β Receptor Blockers
Market segment by Application can be divided into
- Medical Treatment of Hyperthyroidism
- Preparation for Thyroid Surgery
- Treatment of Thyroid Crisis
The key market players for global Antithyroid Drug market are listed below:
- Shanghai Huanghai Pharmaceutical Co., Ltd
- Merck KGaA
- Lomapharm Rudolf Lohmann GmbH KG
- Herbrand Pharmaceutical Chemistry Co., Ltd
- Beijing Tongjida Pharmaceutical Co., Ltd
- Shanghai Zhaohui Pharmaceutical Co., Ltd
- Guangzhou Kanghe Pharmaceutical Co., Ltd
- Hunan Hansen Pharmaceutical Co., Ltd
- World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
- Haimani Pharmaceutical Co., Ltd
- Shanghai McLin Biochemical Technology Co., Ltd
- Shanghai Yuanye Bio-Technology Co., Ltd
- Amgen Inc
- AbbVie Deutschland GmbH & Co.KG
- Centrix Pharmaceutical Inc.
- Pfizer Inc.
- Actavis Totowa LLC
- Caraco Pharmaceutical Laboratories
- Boca Pharmacal Inc.
- Heritage Pharmaceuticals Inc.
- Par Pharmaceutical Inc
- Sandoz Pharmaceuticals Inc.
The standard report covers the below regions and countries -
- North America Region Covering - (United States, Canada and Mexico)
- Europe Region Covering - (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific Region Covering - (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America Region Covering - (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa Region Covering - (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
We also provide customized report covering specific countries/companies or segments on request.